Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
PanDrugs2 is the new version of PanDrugs currently indicated on pandrugs.org. The page describes it as the “most recent update,” with new features and databases, while keeping the old version available for six months. The navigation bar includes Query, PanDrugs in TCGA, API, Help, FAQs, Citation, Sources, Privacy Policy, Terms of Use, and Login, suggesting that it is more of an online query and data service tool for pharmacogenomics or cancer genomics research.
Based on the visible text, PanDrugs2 at least provides a web-based query interface, a TCGA-related entry point, and an API section. It also includes citation and data source information, making it suitable for research scenarios where data provenance and paper citations need to be tracked. However, the main body captured during crawling is actually the default Apache Tomcat 8.0.53 documentation index, covering Tomcat features such as Servlet 3.1, JSP 2.3, JNDI, JDBC, SSL/TLS, WebSocket, clustering, and monitoring, rather than a product description for PanDrugs2. Therefore, its specific algorithms, supported input formats, drug database coverage, or analysis report contents cannot be inferred from this text.
The page does not disclose pricing, commercial licensing, payment methods, or usage restrictions. The navigation includes License and API, but the body text does not provide license terms, API endpoints, authentication methods, rate limits, SDKs, or sample code. There is also no information about self-hosting, Docker, source code repositories, or local deployment. The only clear deployment clue is that the site exposes Tomcat documentation, but this should not be interpreted as evidence of product-level self-hosting capability.
The main advantage is that the site structure shows common modules found in research tools, including query, TCGA, API, FAQs, sources, and citations. It is also marked as version 2024.06, suggesting that it is still being maintained. The downside is that very little effective product information was captured in this review, and the presence of default Tomcat documentation reduces confidence in the completeness of the documentation and operational configuration. It is better suited for bioinformatics, cancer genomics, and pharmacogenomics researchers who want to try it online first. If it is to be used in production-grade workflows, the API documentation, data licensing, availability, and citation requirements should be further verified.
Access conditions from mainland China cannot be determined from the text, and payment information is also missing. If access is unstable, researchers would typically consider similar pharmacogenomics or cancer variant annotation databases as alternatives, but the text reviewed here does not provide specific alternative product names for direct comparison.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pandrugs.org official site.
pandrugs.org is an Unknown API & Data provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach pandrugs.org directly.